AnthonyAMeluchMD

PubMed

• BILATERAL UVEAL METASTASES SECONDARY TO PROSTATE ADENOCARCINOMA.
  Katherine J. Cochran, J. R. Gray, A. A. Meluch, David A. Reichstein> ;Retinal Cases & Brief Reports. 2017 Dec 1
• 12 citations
  A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases ...
  Johanna C. Bendell, Ahmed Zakari, James D. Peyton, Ralph V. Boccia, Mark Moskowitz, Victor G. Gian, Andrew Lipman, David M. Waterhouse, Richard LoCicero, Chris Earwood...> ;The Oncologist. 2016 Mar 1
• A Phase II Trial of Preoperative Concurrent Chemotherapy/Radiation Therapy Plus Bevacizumab/Erlotinib in the Treatment of Localized Esophageal Cancer.
  Bendell, J. C., Meluch, A., Peyton, J., Rubin, M., Waterhouse, D., Webb, C., Burris, H. A., Hainsworth, J. D.> ;Clin Adv Hematol Oncol. 2012 Jul
• High-dose bevacizumab in the treatment of patients with advanced clear cell renal carcinoma (RCC): A Sarah Cannon Research Institute phase II trial.
  Meluch AA, Shipley D, Waterhouse DM, Reeves JA, Arrowsmith E, Spigel DR, Hainsworth JD> ;J. Clin. Oncol.. 2011-05-20
• Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate Cancer.
  Scher, H.I., Jia, X., Chi, K., de Wit, R., Berry, W.R., Albers, P., Henick, B., Waterhouse, D., Ruether, D.J., Rosen, P.J., Meluch, A.A., Nordquist, L.T., Venner, P.M....> ;J Clin Oncol. 2011 Jun 1
• Combined modality treatment with chemotherapy, radiation therapy, bevacizumab, and erlotinib in patients with locally advanced squamous carcinoma of the head and neck:...
  Hainsworth JD, Spigel DR, Greco FA, Shipley DL, Peyton J, Rubin M, Stipanov M, Meluch A> ;Cancer J. 2011-01-01
• Phase II study of capecitabine in combination with thalidomide in patients with metastatic breast cancer.
  Burris HA, Jones SF, Shipley D, Meluch AA, Greco FA, Barton JH, Yardley DA, Hainsworth JD> ;Cancer Invest.. 2010-05-01
• Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal...
  Spigel, D.R., Greco, F.A., Meluch, A.A., Lane, C.M., Farley, C., Gray, J.R., Clark, B.L., Burris, H.A., Hainsworth, J.D.> ;J Clin Oncol. 2010 May 1
• Single agent vinflunine in the salvage treatment of patients with castration-resistant prostate cancer: a phase II trial of the Sarah Cannon research consortium.
  Hainsworth JD, Meluch AA, Lane CM, Spigel DR, Burris HA, Gandhi JG, Crane EJ, Stipanov MA, Greco FA> ;Cancer Invest.. 2010-03-01
• Combined modality therapy with radiation therapy (RT), chemotherapy, bevacizumab, and erlotinib in the treatment of patients (pts) with locally advanced squamous carci...
  Meluch AA, Spigel D, Burris HA, Lane C, Peyton JD, Shipley D, Rubin M, Stipanov M, Greco FA, Hainsworth JD> ;J. Clin. Oncol.. 2009-05-20
• Vinflunine (VFL) as salvage chemotherapy in hormone-refractory prostate cancer (HRPC).
  Meluch AA, Spigel DR, Burris HA, Greco FA, Gandhi J, Crane E, Markus TM, Hainsworth JD> ;J. Clin. Oncol.. 2008-05-20
• Platelet-derived growth factor receptor inhibition and chemotherapy for castration-resistant prostate cancer with bone metastases.
  Mathew, P., Thall, P.F., Bucana, C.D., Oh, W.K., Morris, M.J., Jones, D.M., Johnson, M.M., Wen, S., Pagliaro, L.C., Tannir, N.M., Tu, S., Meluch, A.A., Smith, L., Cohe...> ;Clin Cancer Res. 2007 Oct 1
• Weekly docetaxel and bortezomib as first-line treatment for patients with hormone-refractory prostate cancer: a Minnie Pearl Cancer Research Network phase II trial.
  Hainsworth, J.D., Meluch, A.A., Spigel, D.R., Barton, J., Simons, L., Meng, C., Gould, B., Greco, F.A.> ;Clin Genitourin Cancer. 2007 Mar
• Docetaxel and epirubicin as first-line treatment for patients with metastatic breast cancer: a Minnie Pearl Cancer Research Network Phase II trial.
  Hainsworth, J.D., Yardley, D.A., Spigel, D.R., Meluch, A.A., Rinaldi, D., Schnell, F.M., Greco, F.A.> ;Cancer Invest. 2006-08-01
• Preliminary results of a randomized placebo-controlled double-blind trial of weekly docetaxel combined with imatinib in men with metastatic androgen-independent prosta...
  Mathew P, Thall PF, Johnson MM, Oh WK, Meluch AA, Morris MJ, Troncoso P, Bucana CD, Fidler IJ, Logothetis CJ> ;J. Clin. Oncol.. 2006-06-20
• Phase I study of ispinesib in combination with carboplatin in patients with advanced solid tumors.
  Jones SF, Plummer ER, Burris HA, Razak AR, Meluch AA, Bowen CJ, Williams DH, Hodge JP, Dar MM, Calvert AH> ;J. Clin. Oncol.. 2006-06-20
• Preoperative oxaliplatin (O), docetaxel (D), capecitabine (C), and concurrent radiation therapy (RT) for patients (pts) with localized esophageal cancer: A phase I/II ...
  Barnes EK, Spigel DR, Greco FA, Meluch AA, Yardley DA, Burris HA, Shipley DL, Patton JF, Farley C, Hainsworth JD> ;J. Clin. Oncol.. 2006-06-20
• Long-term follow-up and compilation of two trials utilizing concurrent paclitaxel/carboplatin/infusional 5-FU/radiation therapy (RT) in patients with localized esophag...
  Meluch AA, Greco FA, Spigel DR, Gray JR, Thomas M, Meng C, Bearden JD, Rosenoff SH, Hermann RC, Hainsworth JD> ;J. Clin. Oncol.. 2006-06-20
• Induction chemotherapy + gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients (pts) with locally advanced squamous carcinoma of the h...
  Doss HH, Greco FA, Meluch AA, Gray JR, Spigel DR, Shipley DL, Barton JH, Kuzur ME, Ramsey S, Lunin SD, Hainsworth JD> ;J. Clin. Oncol.. 2006-06-20
• Weekly docetaxel/estramustine phosphate in patients with increasing serum prostate- specific antigen levels after primary treatment for prostate cancer: a phase II tri...
  Hainsworth, J.D., Meluch, A.A., Spigel, D.R., Yost, K., Meng, C., Greco, F.A.> ;Clin Genitourin Cancer. 2006 Mar
• Fludarabine/rituximab (FR) followed by alemtuzumab as first-line treatment for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL): A ...
  Liggett WH, Hainsworth JD, Spigel DR, Meluch AA, Raefsky EL, Kennedy S, Thomas M, Grimaldi M, Saez RA, Greco FA> ;J. Clin. Oncol.. 2005-06-01
• Weekly docetaxel and bortezomib in the treatment of patients with advanced hormone refractory prostate cancer (HRPC): A Minnie Pearl Cancer Research Network phase II t...
  Meluch AA, Spigel DS, Greco FA, Barton JH, Messina G, Gould B, Rovito MA, Hainsworth JD> ;J. Clin. Oncol.. 2005-06-01
• Concurrent paclitaxel/carboplatin/infusional 5-FU/radiation therapy (RT) with or without subsequent esophageal resection in patients with localized esophageal cancer: ...
  Gray JR, Hainsworth JD, Meluch AA, Spigel DR, Rosenoff SH, Bradof JE, Hermann RC, Meng C, Greco FA> ;J. Clin. Oncol.. 2005-06-01
• Bevacizumab and erlotinib in the treatment of patients with metastatic renal carcinoma (RCC): Update of a phase II multicenter trial.
  Spigel DR, Hainsworth JD, Sosman JA, Raefsky EL, Meluch AA, Edwards D, Horowitz P, Thomas K, Yost K, Stagg MP, Greco FA> ;J. Clin. Oncol.. 2005-06-01
• Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium.
  Raccuglia, G.> ;Cancer. 2005 Jun 1
• Join now to see all

Abstracts/Posters

• A Phase 2 Study to Assess the Feasibility and Tolerance of the Combination of Elotuzumab, Lenalidomide, and Dexamethasone (ERd) in the Induction, Consolidation, and Ma...
  Anthony A. Meluch, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019